- Home
- ESPR vs NXJ Comparison
ESPR vs NXJ Comparison
Compare ESPR & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- NXJ
- Stock Information
- Founded
- ESPR 2008
- NXJ 1999
- Country
- ESPR United States
- NXJ United States
- Employees
- ESPR N/A
- NXJ N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- NXJ Finance/Investors Services
- Sector
- ESPR Health Care
- NXJ Finance
- Exchange
- ESPR Nasdaq
- NXJ Nasdaq
- Market Cap
- ESPR 456.6M
- NXJ 520.4M
- IPO Year
- ESPR 2013
- NXJ N/A
- Fundamental
- Price
- ESPR $2.52
- NXJ $12.22
- Analyst Decision
- ESPR Buy
- NXJ
- Analyst Count
- ESPR 3
- NXJ 0
- Target Price
- ESPR $8.17
- NXJ N/A
- AVG Volume (30 Days)
- ESPR 5.2M
- NXJ 74.9K
- Earning Date
- ESPR 11-07-2024
- NXJ 01-01-0001
- Dividend Yield
- ESPR N/A
- NXJ 3.27%
- EPS Growth
- ESPR N/A
- NXJ N/A
- EPS
- ESPR N/A
- NXJ N/A
- Revenue
- ESPR $295,451,000.00
- NXJ N/A
- Revenue This Year
- ESPR $198.22
- NXJ N/A
- Revenue Next Year
- ESPR $25.83
- NXJ N/A
- P/E Ratio
- ESPR N/A
- NXJ N/A
- Revenue Growth
- ESPR 187.12
- NXJ N/A
- 52 Week Low
- ESPR $1.16
- NXJ $10.06
- 52 Week High
- ESPR $3.40
- NXJ $12.24
- Technical
- Relative Strength Index (RSI)
- ESPR 64.07
- NXJ 32.21
- Support Level
- ESPR $2.02
- NXJ $12.22
- Resistance Level
- ESPR $2.60
- NXJ $12.51
- Average True Range (ATR)
- ESPR 0.19
- NXJ 0.08
- MACD
- ESPR 0.02
- NXJ -0.00
- Stochastic Oscillator
- ESPR 89.04
- NXJ 6.35
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.